Navigation Links
Taking Control of Diabetes: Support World Diabetes Day (14th November 2010)
Date:10/28/2010

Taking Control of Diabetes: Support World Diabetes Day (14th November 2010) -- LONDON, October 28, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Trade Show News Click to view news release full screen  

Taking Control of Diabetes: Support World Diabetes Day (14th November 2010)

 

LONDON, October 28, 2010 /PRNewswire/ -- Diabetic Hypoglycemia supports World Diabetes Day on the 14th November 2010 in raising the global awareness of diabetes ( http://www.worlddiabetesday.org/).

The theme of World Diabetes Day in 2010 is "Let's take control of diabetes. Now", which marks the second year of the five-year focus on diabetes education and prevention, the theme selected by the International Diabetes Federation and the World Health Organization for World Diabetes Day 2009-2013. The focus of the campaign is to raise awareness of diabetes in the general public, those with diabetes and those at risk. Tools to improve knowledge of diabetes will be disseminated in an attempt to prevent diabetes and/or its complications. It is also a major aim of the campaign to inform governments and policy-makers of the cost-effective implications of diabetes prevention strategies and diabetes education.

In the latest issue of Diabetic Hypoglycemia, Dr Ana Maria Arbelaez and Dr Tamara Hershey from the Washington University School of Medicine, St Louis, USA discuss the effects of hypoglycemia on brain structure and function and how neuroimaging tools can be used to measure these effects over the short, intermediate and long-term. They also describe the areas of the brain thought classically to be particularly susceptible to damage from hypoglycemia, and how technologic advances in imaging techniques show that the brain regions thought to be particularly affected may not be correct. Professor Anthony McCall's related editorial details key points of interest in the feature article and points out the particular vulnerability of the developing brain to hypoglycemia.

About Diabetic Hypoglycemia

Published by ESP Bioscience (Crowthorne, UK), Diabetic Hypoglycemia is an influential online diabetes journal led by Editor-in-Chief Professor Brian Frier (Edinburgh, UK), with Associate Editors: Professor Simon Heller (Sheffield, UK), Professor Christopher Ryan (Pittsburgh, USA), Dr Rory McCrimmon (Dundee, UK), and Professor Anthony L. McCall (Virginia, USA). Published three times annually, Diabetic Hypoglycemia provides an interactive forum for the sharing of practical knowledge and opinions in the field of hypoglycemia.

To explore Diabetic Hypoglycemia, please take the guided tour: http://www.hypodiab.com/Teaser/hypodiab.html.

Diabetic Hypoglycemia is published by ESP Bioscience, supported by an unrestricted educational grant from Novo Nordisk A/S (Bagsvaerd, Denmark).

Contact: Editorial Office E: enquiries@hypodiab.com T: +44-(0)1344-762531 F: +44-(0)203-0514753
'/>"/>

SOURCE ESP Bioscience
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. WAVE Conference and Exhibition 2011 Taking Products to Market incorporating Micro & Nano Technology
2. Gloabl Harvest Initiative: Taking Down Fences To Meet Future Needs
3. Patton Medical Devices Partners With Unomedical to Develop and Market the i-port Advance(TM) Injection Port for People Taking Multiple Daily Injections
4. Diagnostic Imaging to Deliver Its 11th Annual Webcast of Key Events Taking Place at RSNA 2008
5. Miniaturizing memory: Taking data storage to the molecular level
6. Lotus Pharmaceuticals Announces New Patent for Controlled-Release Diabetes Drug
7. HumanTouch Expands Services to the Centers for Disease Control and Prevention as a Prime Contract Holder as Part of $1.0 Billion Contract
8. The perfect nanocube: Precise control of size, shape and composition
9. Marrone Bio Innovations to Present Invasive Mussel Control Solution
10. Powerful new way to control magnetism
11. Phase III Randomised Controlled Trial Confirms Clinical Efficacy and Safety of Radioembolisation Using 90Y-resin Microspheres for Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... , ... February 06, 2016 , ... ... , The Center for Excellence in Education Sponsors Teacher Training Program , ... February 4, 2016 – The Center for Excellence in Education (CEE) will sponsor ...
(Date:2/5/2016)... February 5, 2016 Amarantus BioScience ... company focused on developing products for Regenerative Medicine, Neurology ... Pediatric Disease Designation (RPDD) from the US Food and ... MANF. MANF was previously granted orphan drug designation (ODD) ... Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), ...
(Date:2/4/2016)... Feb. 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today that Edward Lanphier , Sangamo,s president and ... progress of Sangamo,s ZFP Therapeutic ® development programs ... 2:40 pm ET on Thursday, February 11, 2016, at ... Conference. The conference is being held in ...
(Date:2/4/2016)... 2016  CytoSorbents Corporation (NASDAQ: CTSO ), ... CytoSorb® blood filter to treat deadly inflammation in ... announced that CEO Dr. Phillip Chan , ... Group,s 2016 Disruptive Growth & Healthcare Conference, providing ... Conference Presentation Details: Where: Convene Conference ...
Breaking Biology Technology:
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of the bioinformatic market by reviewing the recent ... enabled tools that drive the field forward. Includes ... to: Identify the challenges and opportunities that ... providers and software solution developers, as well as ...
(Date:2/2/2016)... , Feb. 2, 2016   Parabon NanoLabs ... the U.S. Army Research Office and the Defense ... and sensitivity of the company,s Snapshot Kinship ... Mission and, more generally, defense-related DNA forensics.  Although ... capabilities (predicting appearance and ancestry from DNA evidence), ...
(Date:2/1/2016)... NEW YORK , Feb. 1, 2016  Today, ... Heart Association (AHA) announced plans to develop a first ... cognitive computing power of IBM Watson. In the first ... disease, AHA, IBM (NYSE: IBM ), and Welltok ... metrics and health assessments with cognitive analytics, delivered on ...
Breaking Biology News(10 mins):